Systemic administration of liposomal encapsulated [beta]- galactosidase: a model to investigate the development of therapeutic protein drug
With advances in recombinant protein technology, a growing number of therapeutic protein products have become available for clinical applications. But their wide use is limited by poor biodistribution, limited circulation time and the generation of immune responses to the drug by the patient. The...
Main Author: | Mok, Wilson Wing Ki |
---|---|
Language: | English |
Published: |
2009
|
Online Access: | http://hdl.handle.net/2429/7783 |
Similar Items
-
Systemic administration of liposomal encapsulated [beta]- galactosidase: a model to investigate the development of therapeutic protein drug
by: Mok, Wilson Wing Ki
Published: (2009) -
Liposomal Drug Encapsulation in the Treatment of Rheumatoid Arthritis
by: Shaw, I. H.
Published: (1977) -
Silica based materials for the encapsulation of β-Galactosidase
by: Pavel-Licsandru, Ileana-Alexandra
Published: (2017) -
Studies on Beta-galactosidase of kluyveromyces
by: Joshi, M S
Published: (2007) -
Liposomal Encapsulated Rhodomyrtone: A Novel Antiacne Drug
by: Julalak Chorachoo, et al.
Published: (2013-01-01)